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Importance. Oftentimes, when patients with metastatic cancer present with acute encephalopathy, it is suspected to be secondary
to their underlying malignancy. However, there are multiple causes of delirium such as central nervous system (CNS) infections,
electrolyte abnormalities, and drug adverse reactions. Because West Nile Virus (WNV) neuroinvasive disease has a high mortality
rate in immunosuppressed patients, a high index of suspicion is required in patients who present with fever, altered mental status,
and other neurological symptoms. Observations. Our case report details a single patient with brain metastases who presented with
unexplained fever, encephalopathy, and new-onset tremors. Initially, it was assumed that his symptoms were due to his underlying
malignancy or seizures. However, because his unexplained fevers persisted, lumbar puncture was pursued. Cerebrospinal fluid
analysis included WNV polymerase chain reaction and serologies were ordered which eventually led to diagnosis of WNV
encephalitis. Conclusions and Relevance. Patients with metastatic cancer who present with encephalopathy are often evaluated
with assumption that malignancy is the underlying etiology. This can lead to delays in diagnosis and possible mistreatment. Our
case highlights the importance of maintaining a broad differential diagnosis and an important diagnostic consideration of WNV
encephalitis in patients with cancer.
1. Case Report
A 58-year-old male presented in the summertime with fever,
generalized weakness, and encephalopathy after being found
unconscious. Upon arrival to the hospital, he was disoriented
to place and time, dysarthric, and amnestic to details of
the event. Review of systems was positive for one week
of progressive gait instability but negative for any other
preceding or ongoing infectious or neurologic symptoms. He
had no recent travel or exposure to sick contacts.
Seven months prior to his presentation, the patient had
been diagnosed with a poorly differentiated neuroendocrine
carcinoma, which presented primarily in his parotid gland.
He had completed seven cycles of chemotherapy, with the
last cycle given two weeks previously. Two months earlier,
he had developed numerous asymptomatic brain metastases.
A whole-brain radiation therapy was recommended for
him; however, he declined. Other chronic medical prob-
lems included a history of prostate cancer in remission,
dyslipidemia, and hypertension. He also had a history of
“visual seizures” for which he was taking daily antiepileptic
medication.
On presentation, the patient was somnolent but arous-
able. His vital signs revealed that he was febrile (temperature
of 102.4 F) and tachycardic (heart rate of 126), blood pressure
was 150/105mmHg, respiratory rate was 14, and oxygen
saturation was 95% on 2 liters per minute nasal cannula.
Cardiopulmonary and gastrointestinal examinations were
otherwise unremarkable. On neurological examination, the
patient exhibited a resting tremor in both upper extremities,
which his family reported was new within the past few
days. There was no evidence of tongue biting, urinary incon-
tinence, photophobia, or nuchal rigidity. Muscle strength,
tone, and deep tendon reflexes were normal and symmetric.
Babinski signswere absent. Sensory examinationwas normal.
Laboratory evaluation was significant only for mild
hyponatremia (132mmol/L) and elevated creatinine kinase
(236mmol/L). Tests for liver function, complete blood count,
and urinalysis were unremarkable. Blood cultures and urine
cultures were sent upon presentation and eventually revealed
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no growth. Urine drug screen was positive for cannabinoids
only. Chest radiograph revealed no acute abnormalities.
A noncontrasted head computed tomography was unre-
markable with poor visualization of his known intracranial
metastases. Initially, there was suspicion for an infectious eti-
ology or progression of previously known brain metastases;
therefore, the patient was started on empiric broad-spectrum
antibiotics and systemic glucocorticoids for potential vaso-
genic edema until further diagnostic evaluation could be
performed. His antiseizure medication was also continued.
One day after presentation, the patient’s mental status was
remarkably improved, although not completely to baseline.
The transient nature of his encephalopathy raised suspicion of
a generalized seizure as the inciting event with resultant tem-
porary postictal state. Given this, an electroencephalogram
(EEG) was obtained, revealing mild-to-moderate general-
ized background slowing, indicating diffuse encephalopathy,
without any epileptogenic foci identified.
Two days after presentation, the patient remained febrile
and tremulous; however, his cognition continued to improve.
Because no definitive diagnosis had been reached and he
continued to have unexplained fevers, a lumbar puncture was
performed for further evaluation. Cerebrospinal fluid (CSF)
studies revealed lymphocytic inflammation with an elevated
glucose (84mg/dL), elevated protein (89mg/dL), and ele-
vated total nucleated cell count (95/cumm), with a differential
of neutrophils 8%, lymphocytes 53%, plasma cells 25%, and
monocytes 14%. CSF Gram stain was negative, and cytology
was negative for malignant cells. Herpes Simplex Virus-1
(HSV-1) and HSV-2 reverse transcription-polymerase chain
reaction (RT-PCR) tests were negative, as was Cryptococcus
neoformans antigen. CSF and serologic testing for West Nile
Virus (WNV) IgM, IgG, and PCR was also ordered.
Approximately one week after presentation, a final diag-
nosis of acute WNV encephalitis was made. Although CSF
IgG and PCR for WNV were negative, the patient’s serum
and CSF WNV IgM were qualitatively positive, establish-
ing the diagnosis of WNV neuroinvasive disease [5, 8].
Empiric antibiotics and steroids were discontinued. Brain
magnetic resonance imaging was obtained, which revealed
stable intracranial metastases compared to onemonth earlier.
Over a period of several days, his mental status improved
completely to baseline and his fever and tremors subsided. He
did, however, continue to have significant diffuse weakness,
presumably secondary to prolonged hospital stay and sys-
temic glucocorticoids. The patient was eventually discharged
to a subacute rehabilitation facility.
2. Discussion
Oftentimes, when patients with metastatic cancer present
with acute encephalopathy, it is suspected to be secondary
to their underlying malignancy. Supporting this rationale
is the fact that brain metastases affect 20 to 40 percent
of cancer patients who are hospitalized, and neurologic
complications are one of the most common reasons for their
hospitalization [9]. Nevertheless, other causes of delirium,
specifically central nervous system (CNS) infections, elec-
trolyte abnormalities, vitamin deficiencies, seizures, and drug
Table 1: Infectious and noninfectious causes of encephalitis.





HSV-1, HSV-2 PCR Adverse drugreactions
VZV PCR, virus-specificantibody ADEM
EBV PCR CNSvasculitis





Toxoplasma gondii PCR, culture
Trypanosoma cruzi PCR, culture
Fungi
Cryptococcus neoformans India ink,cryptococcal antigen





HSV, Herpes Simplex Virus; VZV, Varicella Zoster Virus; EBV, Epstein-
Barr Virus; HIV, Human Immunodeficiency Virus; WNV, West Nile Virus;
TBEV, tick-borne encephalitis virus; JEV, Japanese encephalitis virus;MRSA,
methicillin-resistant Staphylococcus pneumonia; CSF, cerebrospinal fluid;
PCR, polymerase chain reaction; ELISA, enzyme-linked immunosorbent
assay; ADEM, Acute Disseminated Encephalomyelitis; CNS, central nervous
system.
References: [1–4].
adverse effects, should be considered on initial evaluation.
In a retrospective review by De la Cruz et al., opioid-
related delirium accounted for 47.31% of missed delirium
cases in cancer patients [10]. Primary CNS infection warrants
specific consideration in the workup of delirium in cancer
patients noting that 16% of patients with CNS infections
have primary CNS tumors [11]. Table 1 lists infectious and
noninfectious causes of meningoencephalitis worldwide that
may affect immunocompromised patients, including cancer
patients [11].
Although uncommon in the healthy population, WNV
has an increased incidence in immunocompromised patients
[12]. WNV can be a difficult diagnosis to make. It requires
a high index of suspicion as presenting symptoms are
nonspecific and initial brain imaging may reveal no abnor-
malities [12]. The presentation of WNV infection can vary
from asymptomatic to a mild, febrile flu-like syndrome
to more severe neurological symptoms. Less than 1% of
individuals develop neuroinvasive disease, which manifests
as meningitis, encephalitis, or polio-like flaccid paralysis [13].
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Table 2: Diagnostic tests for acute West Nile Virus infection.
Test Sensitivity Specificity
PCR (serum) 10% 100%
PCR (CSF) 55% 100%
WNV-specific IgM (serum) 95% 90%
WNV-specific IgM (CSF) 95% 92%
PCR, polymerase chain reaction; CSF, cerebrospinal fluid; WNV, West Nile
Virus.
References: [1, 5–7].
Symptoms such as tremors, myoclonus, or extrapyramidal
symptoms may be seen. Immunosuppressed patients, such
as those receiving chemotherapy, are at higher risk for
neuroinvasive disease [12]. Mortality rate can reach as high
as 20% in these populations [14]. Treatments with interferon,
intravenous immunoglobulin, and ribavirin have been used
but lack high efficacy. Therefore, only supportive measures
are recommended in most cases.
In our patient, workups of systemic infection, including
blood cultures, urine cultures, and chest imaging, were
all negative. CSF evaluation was pursued only after the
patient’smental status and fevers did not improvewith broad-
spectrum antibiotics. Although CSF IgG and PCR for WNV
were negative, this is common in acuteWNV infection, given
their low sensitivity [5]. Both serum and CSF IgM were
positive, which is the gold standard for diagnosis of acute
WNV encephalitis [15]. WNV-specific IgM antibodies are
detectable 3 to 8 days after onset of illness and typically persist
up to 90 days, whereasWNV-specific IgG is detectable after 7
days of illness onset and persists indefinitely [8, 16]. A positive
IgM result combined with a negative IgG result suggests
acute infection [16]. Table 2 illustrates the sensitivities and
specificities of various diagnostic tests for WNV infection.
As described above, patients with metastatic cancer who
present with encephalopathy are often evaluated with the
assumption that malignancy is the underlying etiology. This
can lead to delays in diagnosis and possible mistreatment. To
date, there have been few case reports detailing the course
of WNV infection in patients with malignancy. Our case
highlights the importance of maintaining a broad differential
diagnosis as well as a relatively rare but important diagnostic
consideration of WNV encephalitis in this patient popula-
tion. Because of its high mortality rate in immunosuppressed
patients, timely diagnosis of WNV neuroinvasive disease
should be made to ensure proper monitoring and supportive
measures. It is therefore critical that multiple etiologies be
considered in theworkup of acute delirium in the patientwith
malignancy as determining the underlying diagnosis may
obviate unnecessary diagnostic interventions and empiric
treatments that could have adverse effects.
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